|How selenium in broccoli may fight melanoma|
The mineral selenium, which naturally occurs in foods like broccoli and garlic, appears to slow down a process that allows cancers such as melanoma, prostate cancer, and leukemia to spread. These types of cancer contain mechanisms that block the body's ...
Futurity: Research News - Wed, 26 Nov 2014 08:18
|Selenium Compounds Boost Immune System To Fight Against Cancer|
RedOrbit - Mon, 24 Nov 2014 03:15
|Cancer Cure: Broccoli, Garlic Compound Highly Promising|
International Business Times, India Edition - Thu, 27 Nov 2014 03:48
|How garlic and broccoli help fight cancer|
Daily News & Analysis - Tue, 25 Nov 2014 05:51
|Study links blue eyes with an increased risk for melanoma|
Kids with a blue eye gene variant were more likely to develop moles, especially if they took more beach vacations. Past studies have shown moles and freckling are often precursors to melanoma later in life. Experts say this risk can be significantly ...
KSBY San Luis Obispo News - Tue, 25 Nov 2014 03:48
|Blue-Eyed People May Face Higher Melanoma Risk|
WEDNESDAY, Nov. 19, 2014 (HealthDay News) -- New research suggests that genes tied to blue eyes and red hair could put people at higher risk for moles or freckling in childhood, which are often precursors to the deadly skin cancer melanoma later in life.
WebMD - Wed, 19 Nov 2014 06:03
|Bristol-Myers immunotherapy shows promise to replace chemo for melanoma|
(Reuters) - Chemotherapy as a treatment for advanced melanoma could soon become obsolete, researchers said on Sunday, after patients taking an experimental immuno-oncology drug from Bristol-Myers Squibb Co had a much higher survival rate and had ...
Reuters - Sun, 16 Nov 2014 00:37
|Nivolumab First-line in Melanoma: New Standard of Care?|
Medscape - Mon, 17 Nov 2014 10:11
|Bristol-Myers adds to impressive Opdivo survival data with PhIII melanoma results|
FierceBiotech - Sun, 16 Nov 2014 04:30
|Nivolumab Extends Survival in Phase III Melanoma Study|
OncLive - Mon, 17 Nov 2014 08:27
|Nivolumab bests dacarbazine for melanoma survival|
Skin and Allergy News Digital Network - Mon, 17 Nov 2014 08:04
|Thin melanomas cause greater number of deaths|
“We wanted to know whether the people dying from melanoma were mostly those who had 'slipped through the net' and were presenting to medical care with thick (advanced) melanomas,” David Whiteman, who led the study, told Reuters Health in an email.
Reuters - Thu, 13 Nov 2014 09:26
|Thinner Melanomas Are More Dangerous, Study Says|
Design & Trend - Thu, 13 Nov 2014 18:03
|Scientists Discover Why Patients Respond to a Life-Saving Melanoma Drug|
Newswise — UCLA researchers have pioneered a new methodology to predict why some patients battling advanced melanoma respond well or not at all to the new breakthrough drug pembrolizumab (Keytruda). The study, led by UCLA Jonsson ...
Newswise (press release) - Wed, 26 Nov 2014 09:26
|SU2C-supported research discovers why patients respond to a life-saving ...|
Science Codex - Wed, 26 Nov 2014 10:22
|UCLA study paves the way to more effective melanoma treatment|
Examiner.com - Wed, 26 Nov 2014 10:22
|UCLA scientists discover why some patients respond to a life-saving melanoma ...|
HealthCanal.com - Wed, 26 Nov 2014 10:11
|Combo Treatment for Advanced Melanoma|
Melanoma is the most serious form of skin cancer. In the United States, more than 12,000 people die from advanced melanoma each year, the U.S. Centers for Disease Control and Prevention reports. Caught early, melanoma is treatable. And advances such ...
WebMD - Tue, 04 Nov 2014 14:35
|Combo Treatment for Advanced Melanoma Seems to Improve Survival|
U.S. News & World Report - Tue, 04 Nov 2014 13:30
|Adding GM-CSF to Ipilimumab Improves OS, Lowers Toxicity in Advanced ...|
OncLive - Wed, 05 Nov 2014 14:29
|Combo Treatment Boosts Melanoma Survival|
Newsmax Health - Tue, 04 Nov 2014 13:00
|Melanoma Survival Better With Immune Booster|
Drug Discovery & Development - Wed, 05 Nov 2014 11:13
|Study Finds Mechanism Behind Melanoma Patients' Response to Pembrolizumab|
The study, titled “PD-1 blockade induces responses by inhibiting adaptive immune resistance”, aimed at understanding the mechanisms by which the patient's immune system could be controlled to fight against melanoma. This resulted in the development of ...
Melanoma News Today - Fri, 28 Nov 2014 03:37